Automate Your Wheel Strategy on CI
With Tiblio's Option Bot, you can configure your own wheel strategy including CI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CI
- Rev/Share 1033.8552
- Book/Share 157.9781
- PB 1.8015
- Debt/Equity 0.8143
- CurrentRatio 0.8279
- ROIC 0.0718
- MktCap 75644693106.0
- FreeCF/Share 27.9641
- PFCF 10.1714
- PE 12.6425
- Debt/Assets 0.2156
- DivYield 0.0213
- ROE 0.1459
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 3
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CI | Goldman | -- | Buy | -- | $370 | Oct. 14, 2025 |
| Downgrade | CI | Bernstein | Outperform | Market Perform | -- | $323 | Feb. 6, 2025 |
News
Here's Why Cigna (CI) is a Strong Momentum Stock
Published: February 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why Cigna (CI) is a Top Growth Stock for the Long-Term
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
Published: February 05, 2026 by: Seeking Alpha
Sentiment: Neutral
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
Read More
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
CI's Q4 adjusted EPS beats estimates as Evernorth growth and higher specialty volumes offset fewer medical customers and elevated costs.
Read More
Make Your Portfolio Healthy Again: The Cigna Group
Published: February 05, 2026 by: Seeking Alpha
Sentiment: Positive
The Cigna Group stands out as a deeply undervalued healthcare pick, trading at a forward P/E of 9 versus a 10-year average of 13.5. CI targets 10–14% annual adjusted EPS growth long-term, driven by customer growth, pricing, acquisitions, and share repurchases. The stock offers a 2.2% dividend yield with a low payout ratio, supporting continued double-digit dividend growth and a Chowder number near 13.
Read More
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Boom! FTC Squeezes Concessions from Cigna's Express Scripts
Published: February 04, 2026 by: GlobeNewsWire
Sentiment: Neutral
Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmacies Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmacies
Read More
The Cigna Group Foundation Opens 2026 Youth Mental Health Grant Program To Support Youth, Families and Communities
Published: February 03, 2026 by: PRNewsWire
Sentiment: Neutral
With youth mental health challenges at an all-time high, The Cigna Group Foundation's multiyear grant program addresses a critical need for community-based solutions to support kids and teens BLOOMFIELD, Conn., Feb. 3, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), has opened its 2026 Improving Youth Mental Health grant program.
Read More
Will Declining Medical Customers Affect Cigna's Q4 Earnings?
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Negative
CI heads into Q4 earnings with rising Evernorth revenues but falling premiums and medical customers, raising questions about the quarter's overall growth outlook.
Read More
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
Published: January 27, 2026 by: Seeking Alpha
Sentiment: Negative
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
Read More
Hankook Tire Opens New Onsite Health Clinic for Employees and Their Families at Tennessee Plant
Published: January 07, 2026 by: PRNewsWire
Sentiment: Neutral
New Hankook Tire Clinic Powered by Evernorth offers convenient primary and preventive care at the Clarksville, Tenn. manufacturing plant Onsite clinic provides low- or no-cost access for eligible employees, spouses and dependents, including in-person and virtual visits Investment reinforces Hankook Tire's commitment to the health and well-being of its workforce in the Clarksville community CLARKSVILLE, Tenn.
Read More
Cigna Shares on the Couch: Time to Stay Strong or Walk Away Now?
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
CI looks worth holding as Evernorth growth, expanding pharmacy services, cheap valuation and shareholder returns support its long-term outlook.
Read More
Cigna Group: Market Overreacts To PBM Risk, Buy The Dip (Rating Upgrade)
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
Cigna (CI) is upgraded to Buy as downside risk is overdone and valuation is compelling at 9.3x 2025 earnings. CI's diversified business, strong cash flow, and proactive PBM strategy position it well despite regulatory and political headwinds. Recent PBM model changes, specialty pharmacy expansion, and robust buybacks support long-term growth and margin resilience.
Read More
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
Published: December 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Cigna Group (“Cigna” or “the Company”) (NYSE: CI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
Published: December 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Cigna Group (“Cigna” or “the Company”) (NYSE: CI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
New Cigna Research Shows Purpose Can Offset Chronic Disease
Published: December 03, 2025 by: PRNewsWire
Sentiment: Neutral
Less than 1 in 3 Americans Have a Strong Sense of Purpose BLOOMFIELD, Conn. , Dec. 3, 2025 /PRNewswire/ -- New research from The Cigna Group (NYSE:CI) finds that people who have a strong sense of purpose experience far higher vitality, better health, stronger relationships, and greater engagement at work.
Read More
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
Published: December 02, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)---- $CI--CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm.
Read More
Empire State Radiology Joins Cigna Network, Delivering Long-Term Access to Advanced Imaging for New Yorkers
Published: November 25, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Empire State Radiology, P.C. (ESR), a Radiology Partners-affiliated practice, announced a new, multi-year agreement with Cigna Health bringing ESR into Cigna's network of expanding participating providers beginning November 15, 2025. This new partnership strengthens network stability and enhances access for patients, hospitals, and referring physicians across New York ensuring Cigna's members have access to ESR's differentiated and subspecialized diagnostic and interv.
Read More
Cigna Q3 Earnings Beat Estimates on Evernorth Health Unit Strength
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CI's Q3 earnings and revenues beat estimates as Evernorth Health Services powers growth despite healthcare headwinds.
Read More
The Cigna Group (CI) Q3 2025 Earnings Call Transcript
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Neutral
The Cigna Group ( CI ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - CEO & Chair of the Board Brian Evanko - President & COO Ann Dennison - Executive VP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Albert Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Charles Rhyee - TD Cowen, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Kevin …
Read More
Cigna Posts Higher Profit, Revenue as Evernorth Business Continues to Grow
Published: October 30, 2025 by: WSJ
Sentiment: Positive
Cigna Group logged higher profit and revenue in the third quarter, boosted by continued strength in its pharmacy-benefit business Evernorth.
Read More
Cigna (CI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Cigna (CI) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Will Lower Premiums Affect Cigna's Q3 Earnings? Key Insights Here
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
CI's Q3 results hinge on strong Evernorth growth and surging investment income, but lower premiums and rising costs may weigh on margins.
Read More
Ahead of Cigna (CI) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
The Cigna Group Foundation Teamed Up with Community Organizations To Enhance 34,000 Lives with Youth Mental Health Support
Published: October 09, 2025 by: PRNewsWire
Sentiment: Neutral
BLOOMFIELD, Conn. , Oct. 9, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today released its Improving Youth Mental Health 2025 Impact Report, highlighting the transformative effect of its youth mental health initiatives across 10 states.
Read More
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Cigna Approves Coverage for Cleerly's AI Cardiovascular Imaging Technology
Published: September 24, 2025 by: Business Wire
Sentiment: Neutral
DENVER--(BUSINESS WIRE)-- #AI--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The coverage decision makes Cigna the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology for cardiovascular care. With more than 16 million covered lives, Cigna j.
Read More
About Cigna Corporation (CI)
- IPO Date 1982-03-31
- Website https://www.cigna.com
- Industry Medical - Healthcare Plans
- CEO David Michael Cordani
- Employees 71295